The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Insmed Incorporated(NASDAQ:INSM) 
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is...
Website: http://www.insmed.com
Founded: 1988
Full Time Employees: 435
Sector: Healthcare
Industry: Biotechnology
Insmed Days Payable Outstanding ttm (DPO)
Insmed Days Receivable Outstanding ttm (DSO)
Insmed Days Inventory Outstanding ttm (DIO)
Insmed Op Cashflow Per Share ttm
Insmed Free Cashflow Per Share ttm
Insmed Cash Per Share ttm
Insmed P/S ratio ttm
Insmed (GAAP) P/E ratio ttm
Insmed P/B ratio ttm
No extra charts and metrics for this ticker.